documents: FDA-1995-S-0039-0282
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1995-S-0039-0282 | FDA | FDA-1995-S-0039 | NDI 625, Obestilin from Sabinsa Corporation | Other | 75 Day PreMarket Notification | 2012-03-05T05:00:00Z | 2012 | 3 | 2012-03-05T05:00:00Z | 2016-09-30T14:24:28Z | 0 | 0 | 0900006480c1b04e |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref